SIOX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 Feb 2024 @ 15:58):

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases...

Stats
Today's Volume	7 588.00
Average Volume	62 408.00
Market Cap	35.36M
EPS	$0 ( 2024-02-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.226
ATR14	$0.0220 (4.60%)

Insider Trading

Date	Person	Action	Amount	type
2022-02-08	Meswani Parag V	Buy	153 700	Restricted Stock Units
2022-02-08	Nassif David W.	Buy	546 500	Restricted Stock Units
2022-01-28	Meswani Parag V	Sell	0	Common Stock
2022-01-28	Meswani Parag V	Sell	15 625	Stock Option (Right to Buy)
2022-01-28	Meswani Parag V	Sell	12 500	Stock Option (Right to Buy)

INSIDER POWER
0.00
Last 89 transactions
Buy: 137 127 498 \| Sell: 478 048

Volume Correlation

Long: 0.43 (neutral)

Short: 0.16 (neutral)

Signal:(83.213) Neutral

Sio Gene Therapies Inc. Correlation

10 Most Positive Correlations
TACO	0.952
GGAL	0.949
NWLI	0.946
AMYT	0.938
ACIW	0.938
RXDX	0.937
BKCH	0.931
NYMTP	0.93
WLFC	0.929
HWCC	0.928

10 Most Negative Correlations
LARK	-0.941
PCRX	-0.94
GOSS	-0.936
SMMF	-0.935
MARK	-0.928
HMNF	-0.924
THTX	-0.919
USCB	-0.919
RIVN	-0.917
XFOR	-0.915

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sio Gene Therapies Inc. Correlation - Currency/Commodity

0.14
( neutral )

0.11
( neutral )

0.00
( neutral )

0.11
( neutral )

0.00
( neutral )

0.13
( neutral )

Sio Gene Therapies Inc. Financials

Annual	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

FY	2023
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

FY	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$-0.980

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.620

Financial Reports:

No articles found.

Sio Gene Therapies Inc.

Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-GM. The company was formerly known as Axovant Gene Therapies Ltd. and changed its name to Sio Gene Therapies, Inc. in November 2020. Sio Gene Therapies, Inc. was incorporated in 2014 and is based in New York, New York.